Loading...
Loading...
Shares of Theravance
THRX are lower on the session by 7.29%, currently trading at $20.49. The stock has been moving largely lower over the past five weeks and is currently trading below the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the February 2012 $15.00 put, which has traded 2,100 times on open interest of 24 contracts.
Put volume is outpacing call volume by 3 to 1.
Theravance, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in